Recent News

• 04.18.2025 - Christopher J. Raymond
• 04.18.2025 - Christopher J. Raymond
• 04.18.2025 - Roger Song
• 04.18.2025 - Roger Song
• 04.03.2025 - Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa
• 04.03.2025 - Akebia Therapeutics Announces Positive Opinion of European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease Licensed to Averoa
• 04.02.2025 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.02.2025 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.25.2025 - Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025
• 03.25.2025 - Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025

Recent Filings

• 04.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.20.2025 - 8-K Current report
• 03.20.2025 - EX-99.1 EX-99.1
• 03.20.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.19.2025 - 424B5 Prospectus [Rule 424(b)(5)]